The aim of the present study was to evaluate the association of plasma biomarkers of inflammation (CRP) and oxidative stress (oxLDL) with the development of clinically evident vascular disease (arterial hypertension, cerebrovascular disease, coronary/peripheral arterial disease, and pulmonary embolism) in lone AF patients. This evidence concerns the gene CRP and cerebrovascular disorder.